Fig. 4From: Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilatorGeometric mean (SD) navafenterol plasma concentration at each timepoint over 36 h post-dose (pharmacokinetics population). Data are shown on a semi-logarithmic scale. For error bars, the geometric mean SD is displayed as exponential (arithmetic mean of the natural log-transformed variable ± arithmetic SD of the natural log-transformed variable). SD = standard deviationBack to article page